A framework for identification of actionable cancer genome dependencies in small cell lung cancer. [electronic resource]
Producer: 20121231Description: 17034-9 p. digitalISSN:- 1091-6490
- Apoptosis -- drug effects
- Aurora Kinase B
- Aurora Kinases
- Benzothiazoles
- Cell Line, Tumor
- Cell Survival -- drug effects
- DNA Primers -- genetics
- Diamines
- Enzyme Inhibitors -- pharmacology
- Flow Cytometry
- G2 Phase Cell Cycle Checkpoints -- drug effects
- Humans
- Immunoblotting
- Organic Chemicals
- Phosphoinositide-3 Kinase Inhibitors
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Proto-Oncogene Proteins c-myc -- metabolism
- Quinolines
- Reverse Transcriptase Polymerase Chain Reaction
- Signal Transduction -- drug effects
- Small Cell Lung Carcinoma -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.